Neurocrine Biosciences has started a Phase II clinical trial of NBI-1065890, a selective VMAT2 inhibitor, in adults with TD.The post...
Eisai and Biogen have announced that the US FDA has accepted for review the sBLA submitted by the former for...
The University of Nottingham has announced a collaboration with Italy’s Aboca and specialists from the University’s Sir Peter Mansfield Magnetic...
IGC Pharma has expanded its CALMA Phase II clinical trial by adding Integrative Clinical Trials, based in Brooklyn, New York,...
Daiichi Sankyo and AstraZeneca’s Enhertu has received approval from China’s NMPA for adult patients with locally advanced or metastatic HER2...
SonoMotion has received the US Food and Drug Administration (FDA) 510(k) clearance for its Break Wave non-invasive kidney stone treatment...
Worldwide Clinical Trials has entered a definitive agreement to acquire oncology CRO Catalyst Clinical Research.The post Worldwide Clinical Trials to...
Opna Bio has received the US FDA orphan drug designation for OPN-2853, a BET small molecule inhibitor, to treat myelofibrosis.The...
QT Imaging has signed an exclusive distribution agreement with Al NMC for its QTI Breast Acoustic CT scanners and Cloud...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.